These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27628239)

  • 21. Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease.
    Stykel MG; Humphries K; Kirby MP; Czaniecki C; Wang T; Ryan T; Bamm V; Ryan SD
    FASEB J; 2018 Oct; 32(10):5350-5364. PubMed ID: 29688812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
    Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impairment of microtubule system increases alpha-synuclein aggregation and toxicity.
    Kim M; Jung W; Lee IH; Bhak G; Paik SR; Hahn JS
    Biochem Biophys Res Commun; 2008 Jan; 365(4):628-35. PubMed ID: 18022384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breaking down and building up alpha-synuclein: An insight on its N-terminal domain.
    Peqini K; Attanasio S; Feni L; Cappelletti G; Pellegrino S
    J Pept Sci; 2024 Apr; 30(4):e3556. PubMed ID: 38037257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane.
    Beyer K
    Cell Biochem Biophys; 2007; 47(2):285-99. PubMed ID: 17652776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of motives mediating alternative functions of the neomorphic moonlighting TPPP/p25.
    Tőkési N; Oláh J; Hlavanda E; Szunyogh S; Szabó A; Babos F; Magyar A; Lehotzky A; Vass E; Ovádi J
    Biochim Biophys Acta; 2014 Apr; 1842(4):547-57. PubMed ID: 24463170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SUMOylation of α-tubulin is a novel modification regulating microtubule dynamics.
    Feng W; Liu R; Xie X; Diao L; Gao N; Cheng J; Zhang X; Li Y; Bao L
    J Mol Cell Biol; 2021 May; 13(2):91-103. PubMed ID: 33394042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's disease.
    Basu S; Je G; Kim YS
    Exp Mol Med; 2015 Aug; 47(8):e179. PubMed ID: 26315598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-Synuclein Proximity Ligation Assay (AS-PLA) in Brain Sections to Probe for Alpha-Synuclein Oligomers.
    Roberts RF; Bengoa-Vergniory N; Alegre-Abarrategui J
    Methods Mol Biol; 2019; 1948():69-76. PubMed ID: 30771171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter.
    Wersinger C; Sidhu A
    Biochemistry; 2005 Oct; 44(41):13612-24. PubMed ID: 16216085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulatory Role of TPPP3 in Microtubule Organization and Its Impact on Alpha-Synuclein Pathology.
    Oláh J; Lehotzky A; Szénási T; Berki T; Ovádi J
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DJ-1 Acts as a Scavenger of α-Synuclein Oligomers and Restores Monomeric Glycated α-Synuclein.
    Atieh TB; Roth J; Yang X; Hoop CL; Baum J
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Synuclein accumulation reduces GABAergic inhibitory transmission in a model of multiple system atrophy.
    Ito H; Nakayama K; Jin C; Suzuki Y; Yazawa I
    Biochem Biophys Res Commun; 2012 Nov; 428(3):348-53. PubMed ID: 23098910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA induced folding/fibrillation of alpha-synuclein: new insights in Parkinson's disease.
    Hegde ML; Vasudevaraju P; Rao KJ
    Front Biosci (Landmark Ed); 2010 Jan; 15(2):418-36. PubMed ID: 20036828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death.
    Lopes da Fonseca T; Pinho R; Outeiro TF
    Hum Mol Genet; 2016 Jul; 25(14):2959-2971. PubMed ID: 27282395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice.
    Oliveras-Salvá M; Macchi F; Coessens V; Deleersnijder A; Gérard M; Van der Perren A; Van den Haute C; Baekelandt V
    Neurobiol Aging; 2014 Nov; 35(11):2625-2636. PubMed ID: 25037286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C; Lee SJ
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell Models to Study Cell-to-Cell Transmission of α-Synuclein.
    Bae EJ; Lee HJ; Lee SJ
    Methods Mol Biol; 2016; 1345():291-8. PubMed ID: 26453220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Parkinson's disease-associated H50Q mutation accelerates α-Synuclein aggregation in vitro.
    Ghosh D; Mondal M; Mohite GM; Singh PK; Ranjan P; Anoop A; Ghosh S; Jha NN; Kumar A; Maji SK
    Biochemistry; 2013 Oct; 52(40):6925-7. PubMed ID: 24047453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.